CA1191103A - Production of gamma-decalactone - Google Patents
Production of gamma-decalactoneInfo
- Publication number
- CA1191103A CA1191103A CA000412362A CA412362A CA1191103A CA 1191103 A CA1191103 A CA 1191103A CA 000412362 A CA000412362 A CA 000412362A CA 412362 A CA412362 A CA 412362A CA 1191103 A CA1191103 A CA 1191103A
- Authority
- CA
- Canada
- Prior art keywords
- gamma
- candida
- decalactone
- accordance
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 title claims abstract 12
- 238000004519 manufacturing process Methods 0.000 title description 4
- IFYYFLINQYPWGJ-VIFPVBQESA-N gamma-Decalactone Natural products CCCCCC[C@H]1CCC(=O)O1 IFYYFLINQYPWGJ-VIFPVBQESA-N 0.000 title 1
- 239000004359 castor oil Substances 0.000 claims abstract description 36
- 235000019438 castor oil Nutrition 0.000 claims abstract description 36
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 36
- 244000005700 microbiome Species 0.000 claims abstract description 32
- 239000000413 hydrolysate Substances 0.000 claims abstract description 18
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 8
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 6
- 239000007800 oxidant agent Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 34
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 8
- 102000004882 Lipase Human genes 0.000 claims description 8
- 239000004367 Lipase Substances 0.000 claims description 7
- 235000019421 lipase Nutrition 0.000 claims description 7
- 241000222122 Candida albicans Species 0.000 claims description 6
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 6
- 241000222178 Candida tropicalis Species 0.000 claims description 4
- 241000222175 Diutina rugosa Species 0.000 claims description 4
- 241000235048 Meyerozyma guilliermondii Species 0.000 claims description 4
- 241000878745 Cyberlindnera saturnus Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 244000285963 Kluyveromyces fragilis Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 240000006439 Aspergillus oryzae Species 0.000 claims 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims 3
- 241000178293 Geotrichum klebahnii Species 0.000 claims 3
- 238000011065 in-situ storage Methods 0.000 claims 3
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims 2
- 241000235645 Pichia kudriavzevii Species 0.000 claims 2
- 229940095731 candida albicans Drugs 0.000 claims 2
- 230000001590 oxidative effect Effects 0.000 claims 2
- 229960001777 castor oil Drugs 0.000 description 28
- 239000002609 medium Substances 0.000 description 15
- 239000000758 substrate Substances 0.000 description 15
- 230000008569 process Effects 0.000 description 8
- -1 microbial Natural products 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 3
- 229960003656 ricinoleic acid Drugs 0.000 description 3
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- GHPVDCPCKSNJDR-SECBINFHSA-N (2r)-2-hydroxydecanoic acid Chemical compound CCCCCCCC[C@@H](O)C(O)=O GHPVDCPCKSNJDR-SECBINFHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000159512 Geotrichum Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000235013 Yarrowia Species 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 208000037516 chromosome inversion disease Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 238000007273 lactonization reaction Methods 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 101000911019 Homo sapiens Zinc finger protein castor homolog 1 Proteins 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101100072408 Mus musculus Il21r gene Proteins 0.000 description 1
- 101100494762 Mus musculus Nedd9 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 102100026655 Zinc finger protein castor homolog 1 Human genes 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007775 late Effects 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007483 microbial process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 108091016642 steapsin Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Optically active .gamma.-decalactone is produced by culturing a microorganism capable of hydrolyzing castor oil and effecting .beta.-oxidation of the resulting hydrolysate in the presence of castor oil or castor oil hydrolysate and a co-oxidant. The resulting .gamma.-hydroxydecanoic acid is lactonized to form .gamma.-decalactone.
Optically active .gamma.-decalactone is produced by culturing a microorganism capable of hydrolyzing castor oil and effecting .beta.-oxidation of the resulting hydrolysate in the presence of castor oil or castor oil hydrolysate and a co-oxidant. The resulting .gamma.-hydroxydecanoic acid is lactonized to form .gamma.-decalactone.
Description
l'RODUCri'ION Ofi' y--Di~Ci~T,ACTONE:
s~ KGROUND OF_rL'HE IN-vENrrIo-N
This invention is concerned with a microbial process for the production of optically active y-decalactone.
Considerable time and effort have been expended by microbiologists in the search for be-tter processess for the production of optically active lactones. U.S.
Patent 3,076,~50 discloses a method of preparing cer-tain optically active lactones and the corresponding hydroxycarboxylic acids by microbial reduction,of keto-carboxylic acids. The me-tabolism of ricinoleic acid by some Candida s-trains was inves-tigated by Okui et al.
IJ. Biochemistry, 54,536-540, 1963) who showed that y-hydroxydecanoic acid was an intermediate in the oxi-dative degradation of ricinoleic acid. However, only trace amounts of y-hydroxydecanoic acid were recovered from the fermenta-tion medium due to the rnetabolysis f r-hydroxydecanoic acid upon completion of the fer-mentation,and the toxicity of ricinoleic acid to the microorganism,which limits the amount of substrate that can be used.
SUMMP.RY OF THE INVENTION
_ _ . _ _ This invention provides a method of producing optically active y-hydroxydecanoic acid which comprises culturing or incubating a microorganism capable of hydrolyzing castor oil,and effec-ting ~-oxidation of the resulting hydrolysate in the presence of castor oil,to produce ~-hydroxydecanoi,c acid.
3 ~ 3 rn ano~her clllboclilnellt, ~he invcntion provi,des a mcthod of producillg op-tical,ly active ~--hydroxydecanoic acid which comprise~s enzymatically hyclrolyzillg castor oiL
using l;pase -to form an enzymatic hydrolysate and culturing ox ;ncubati,ng a microorganism capable of effecting ~-oxida-tion of the enzymatic hydrolysate in the presence of said hydrolysa-te to produce ~-hydroxy-decanoic acid.
In still another embodiment, the invention provides a method of producing optically active y-hydroxy-decanoic acid which comprises culturing or incubatirg a microorganism capable of hydrolyzing castor oil and a microorganism capable of effecting ~-oxida-tion of castor oil hydrolysate in -the presence of castor oil to produce y-hydroxydecanoic acid.
DETAILED I:)E CRIPTION _F TI~E_INV NTION
The invention provides a fermen-tation process for -the production of optically active y-hydroxydecanoic acid which may optionally be converted by lactonization to y-decalactone. Depending on the embodiment of the invention employed, the fermentation process involves culturing or incubating a microorganism capable of hydrolyzing castor oil and effecting ~-oxidation of the resulting hydrolysate, or a microorganism capable of effecting ~-oxidation of hydrolysate of castor oil,or a,microorganism capable oE effecting ~-oxidation of an enzymatic hydrolysate of castor oil~ in a suitable medium in the presence of the castor oil or cas-tor oil hydrolysate substrate. The use of cas-tor oil or castor oil hydrolysate as the substrate is deter-mined by -the microorganism(s) employed in the process.
A co-oxidant may ~e added to the culture medium in order to increase the yield of the process.
The selection of the appropriate microorganism for the process is crucial depending on the embodiment of the invention employed, the yield of product required, and the resistance to the toxicity of the fatty acids found in -the castor oil hydrolysate.
The microoryanisms in the inven-tion may be bacteria, yeast or filamentous fungi. Where a microorganism is employed to hydrolyze the castor oil substrate and ~-oxidize the resulting hydrolysate, the preEerred microorganisms are~ erc~_llus oryzae, Candida rUc3Osa~
Geotrichum klebahn~l or _arrow~a llpolytica, (formerly known as Saccharomycopsis lipolytica and previously __ _ Candida _ipolytica), more preferably Yarrowia ~ olytica.
Where the microorganism is employed to only ~-oxidize castor oil hydrolysate, the preferred microorganisms are- Hansenula saturnus, Candida guilliermondii, Candida _bicans r andida krusei, Candida parakrusei, Candida pseudotropicals, Candida stellatoidea,Candida -tropicalis, Asperyi lus oryzae, Candida rugosa, Geot.richum klebahnii or Yarrowia lipoly ica, more __ _ ___ __ __ preferably Candida guilliermondii. Where the 3~ )3 n:icLoor~lLln:ism is used in colllb; nat:ion wi th a 1 :ipase and with castor oi.l, the p:re:Ferrcd Inicroor(J.lnisrns are:
rl lnsellu]a sat-lrn-ls, Ca~ da yu~]llermond:L.L, C~.~nclida alb C~llS, C_ndida ?s~.use , Ca~ da ~aL-akrusel, Candlda ~_udotro~icalis, Cand;da s-te]latoidea, Candida _ . ., ~
tr_e~cal:Ls, As~ .us oryza_, C_ndida _u~Losa, Geo ri.chum kl_bah_il or Yar_ow a ~ lk~t ca, more preferably Candida q~ ermondllO Generally, any type of llpase enzyme may be used to hydrolyze the castor oil, including microbial, pancreatic, fungi or yeast.
I~lerea lipase is used with -the microorganism in the process of the invention, the formation of -the enzymatic hydrolysate may be controlled by limiting the amount of lipase used in the process. This will avold toxicity resulting from the presence of excessive amounts of hydrolysate. The appropria-te amount of lipase require~ may be conveniently found by experimen-tation and will depend upon the lipase and microor-ganism used and the culturing conditions. The hydrolysis using li.pase .is most preferably carried out concur-ren-tly with the fermentation in the same reaction vessel. However, the hydrolysis may be carried out prior to fermentatlon if appropriate measures are taken to avoid the toxic effect of the hydrolysate.
When castor oil is used in the invention, the concern for toxicity is eliminated because triglycerides are not toxic to the organisms. Additionally, the use of castor oil and castor oil hydrolysates as the substrate 3~6 provide co-oxidants to t~e pLocess wh;ch :inc~c.lse efflcierlcy due to the presence of other Eatty acids upon hydrolysis of the castor oil.
s The form in which the microorgan:isms are used is not critlcal. They can be used as -the culture (suspen-sion), i.e., including the cells and the corresponding nutrient solution, or in the form of cells suspended in a buffer solution. The cells or an enzyme extrac-t thereof may be immobilized on a suitable solid support which may then be used to efEec-t the trans-forma-tions .
The cul-ture susperlsion is prepared by inocula-tion of a suitable medium with the m;croorganism. ~ suitable medium is one which contains carbon sources, nitrogen sources, inor~anic salts and growth factors~ Among -the suitable carbon sources are Eor example, glucose, galactose, L-sorbose, rnaltose, sucrose, celloblose, trehalose, L-arabinose, L.-rhamnose, ethanol,glycerol, L-erythri-thol, D-mannitol, lactose, melibiose, raf-finose, meleritose, starch, ~-xylose, D-sorbitol, ~-me-thyl-D-glucoside, lactic acid, ci-tric acid and succinic acidO Among the suitable nitro~en sources are, for example, nitroc3en-containing oryanic substan-ces such as peptone, meat extract, yeast extract, corn steep liquor,and casein, urea, amino acids,or nitro~en COIItailli.11(3 :inorg.~ ic colllpound.s such as nilr.ltes, nitri--les,and inorc3an:ic amnlonium salL-s. ~rnony tllc suitabLe inorganic salts are/ for ex~ ple, phosp}lates, magnes:iuin, potassium, ca]clum~ sodium. The above mentioned nutrients in -the culture ~ned:ium may be supplemented with, for example, one or rnore vitam;ns of the B Group and~or one or more trace minerals such as Fe, Mo, Cu, Mn, B as desired. I-lowever, the process can be per-formedinavitamin--free medium, for example, when a small amount of yeast extract is added to the medium there is no need for vitamins or -trace minerals.
The cultivat:ion of the microorganism can be carried out as a stationary culture or as a submersed culture (e.g., shaking culture, fermentors) preLerably under aerobic conditions. One suitably may work in the pH ranye of Erom about 3.5 to abou-t 8.0, and preferably in the range of from about 4.0 to about 7.5. The pH may be regulated by the addition of inorganic or organic bases, such as sodium hydrox:ide, potassium hydroxide, calcium hydroxide, calcium carbon ate, by ion-exchange resins, or by the addition of a l~uffer such as phosphate or phthalate. The incubation -tem-perature is suitably maintained at between about 15C
and about 33C, with a range from about 20C to about 30~C being preferred.
The process in accordance with the invention is con~
veniently carried out by adding castor oil or castor oil hydrolysate, as the substrate, to the culture medium a~ the onset of cultivation, as the sole carbon source. Alternatively, the substrate may be added in combination with another carbon source, such as c~c~ ose, eitller du~ g c~ll.t.iv.ll-ion, or when cul-tivatioll is comple-te~ 'he amount, level,or conccn(-r.lt:i.on of the subs-t:ra-te in ~he m-di.um may vary. For cxample, in the case of hydro1yzed casl:or oil,levels of f:rom about 0.3~-to abou-t 5~ may make up -the med;um i.nitially or be added during -the course of the fermenta-tion, whereas substantially any level of castor oil may be used.
The reaction time may vary depending on the composition of the culture medium and the substrate concentration.
In general, shaking flask cultures require Erom between about 2h. and about 240h. depending upon the microorganism and the composition oE the cultllre medium. However, when a fermentor is used the Eermen-tation time may be :reduced to ahout 100 h- or less.
The ferMentation may be carr:ied out using the cells of the mlcroorcJanism isolated from the culture solution, or with an enzyme extract isolated from the cells in a manner known per se. In this case, the fermenta-tion can be conveniently carried out in aqueous solution, for example in a buffer solution, in a physiological salt solution, in a fresh nutrient solution~or in water. The isolated cells or enzyme extract may be immobilized on a solid support and the desired trans-formation effected in the absence of the live micro-oxganism~ The transformation of the substrate may be effected by mutants of the microorganism. Such mutants can be obtained readily by methods well known in the art, for example, by exposing the cells to W or X-rays, or customary mutagenic substances such as for example, acridine orange.
The substrate is genercllLy added cl:irectLy to the medium A surface-actlve agent or dispersLon agent, such as Tween ~0*(polyoxyethylenesorbitarl monostearate), can also be added to an aqueous suspenslon of the substrate. Conventional 5 an-tifoam agents, such as silicone oils (e.g. ~CON*), polyalkylenegLycol derivatives, maize oil, or soya oi] can be used to control foaming.
The transformation of the substrate can be monitored using standard analytical techniques such as GLC, TLC, HPLC, IR
and NMR. If a rapid disappearance of the subs-trate is observed, more substrate can then be added in order to maximize the transformation capacity of the microorganisms. The incubation is generally -terminated when all the substrate has disappeared from the culture medium.
After the fermentation process is complete, the ~-hydroxydecanoic acid can either be lactonized in the medium to form ~-decalactone or isolated and purified by conventional -techniques including solvent extraction and distillation. When ln .situ lactonization is desired, the pH of the medium is adjusted to between about 1 and about 5, preferably between about 1 and about 3, by the addition of a suitable acid, such as hydrochloric acid, and the resulting mixture heated to between about 50 C and about 100 C, preferably between ahout 70 C and about 100 C
for about ten minutes, depending upon -the temperature, to convert the ~-hydroxydecanoic acid to y-decalactone. The ~-decalactone is then recovered and purified by standard techniques. If the r-hydroxydecanoic acid is recovered, it may be lactonized according to known procedures ~see, for example, I.L. Finar, Organic Chemis-try, 6th ed.~ Vol.l, p 469 (1973)].
* -trade mark 'L`lle foll.(>w:iT~cl ~'X~llllp~ S S(?:l.VC,' I:.o :i.~ sL::r~ rnbod:irn(~nts oE the :irlvelllion as it is now prcferred l:o practice it ~u-t ;n no way are Inea!lt to ];mit the scope thereof.
Unless othe1-wise stated, we:iyhts are in grams, tempera-tures are in deyrees cen-tic3rade and pressure in mm l~g.
EXAMPLE I
__ _ __ _ A flask containing 100 ml of 2% beef extract and 0.02%
Tween 80 was autoclaved at 120C. for 20 minutes. The medium was then inoculated with 107 cells Yarrowia lipolytica ~Saccharomyco~sls l:L~ol~_i a)/ml of medium, and lOg of castor oil added. The culture was incubated at 26C. on a rotary shaker (200 rpm) for one week The pH of the medium was occasiona]ly adjusted to 6.5-7Ø A-t the end of the Eerrnentation period -the pH of the medium was adjusted to 1.5 by the addition of mineral acid, and the mixture heated at 100C. for 10 minu-tes. AE-ter cooling, the organic products were extracted w;th hexane, the hexane evaporated, and the resiclue dis-tilled to provide 0.61g ~-deca]actone having a GLC purity of 90%.
EXAMPI,E II
The procedures and-rnaterials similar to those descrihed ln Example I were followed~except 0.05g decanoic acid was added each day. There was obtained 0.69g y-decalactone having a GLC purity of 92%.
3~
-- 1.0 --EXAMPLE :r 1 i _ . _ _ . .
The procedures arld mater:ials similaL to those described in Example I, except that Candida guillie mondil was used and 3y were Eollowed of caster oil hydroLysate was added. There was obtained the deslred product-~ -decalactone in 34~ yield.
EXAMPLE IV
By employing the procedures and materials similar to those described in Example I except that lipase is added in conjunction with castor oil, there may be obtained the desired product,'~-decalactone.
EXAMPLE V
By employing the procedures and materials similar to -those described in Examples I, I:[, and III except that other members of the genus Candida such as C. albicans, C krusei lS C. parakrusei, C. pseudotropicalis, C. stellatoldea, C. tropicalis, etc., are used, there may be obtained the desired ~-decalactone.
EXAMPLE VI
By employing the procedures and materials similar to -those described in Example I, except that as a microorganism asperg,illus oryzae is used and 3g of castor oil is added, there is obtained the desired product ~-decalactone (0.3~g/L).
j/~
1~"3~
EX~MPI,E VII
. _ . _, . . _ _ . ... . _ By elllpl.oying lhe procedures and materia].s sim;lar to those descr;bed .in Exalnp].e I, except -that as a micro-organism Geotrichum klebahllii is used alld 3g oE castor oil is added, -there is obtained the desired product y-deca]ac~one (0.2g/L).
EXA~1PLE VIII
By employing the procedures and materials si.milar to those described in Example I, except that as a mi.cro-organism Candida gui.lliernond.ii is used and to each 1,00 ml of medium 100 mg of a lipase (steapsin, Nutritional Biochem Corp.) is added, the des;.red product y-decalactone may be obtai.ned.
The invention being thus described, i.t will be obvious that the sarne may be varied in many ways. Such vari-ations are not to be regarded as a departure from the spirit and scope of the inven-ti.on and all such modlfi-cations are intended to be included within the scope of the fol].owing claims:
s~ KGROUND OF_rL'HE IN-vENrrIo-N
This invention is concerned with a microbial process for the production of optically active y-decalactone.
Considerable time and effort have been expended by microbiologists in the search for be-tter processess for the production of optically active lactones. U.S.
Patent 3,076,~50 discloses a method of preparing cer-tain optically active lactones and the corresponding hydroxycarboxylic acids by microbial reduction,of keto-carboxylic acids. The me-tabolism of ricinoleic acid by some Candida s-trains was inves-tigated by Okui et al.
IJ. Biochemistry, 54,536-540, 1963) who showed that y-hydroxydecanoic acid was an intermediate in the oxi-dative degradation of ricinoleic acid. However, only trace amounts of y-hydroxydecanoic acid were recovered from the fermenta-tion medium due to the rnetabolysis f r-hydroxydecanoic acid upon completion of the fer-mentation,and the toxicity of ricinoleic acid to the microorganism,which limits the amount of substrate that can be used.
SUMMP.RY OF THE INVENTION
_ _ . _ _ This invention provides a method of producing optically active y-hydroxydecanoic acid which comprises culturing or incubating a microorganism capable of hydrolyzing castor oil,and effec-ting ~-oxidation of the resulting hydrolysate in the presence of castor oil,to produce ~-hydroxydecanoi,c acid.
3 ~ 3 rn ano~her clllboclilnellt, ~he invcntion provi,des a mcthod of producillg op-tical,ly active ~--hydroxydecanoic acid which comprise~s enzymatically hyclrolyzillg castor oiL
using l;pase -to form an enzymatic hydrolysate and culturing ox ;ncubati,ng a microorganism capable of effecting ~-oxida-tion of the enzymatic hydrolysate in the presence of said hydrolysa-te to produce ~-hydroxy-decanoic acid.
In still another embodiment, the invention provides a method of producing optically active y-hydroxy-decanoic acid which comprises culturing or incubatirg a microorganism capable of hydrolyzing castor oil and a microorganism capable of effecting ~-oxida-tion of castor oil hydrolysate in -the presence of castor oil to produce y-hydroxydecanoic acid.
DETAILED I:)E CRIPTION _F TI~E_INV NTION
The invention provides a fermen-tation process for -the production of optically active y-hydroxydecanoic acid which may optionally be converted by lactonization to y-decalactone. Depending on the embodiment of the invention employed, the fermentation process involves culturing or incubating a microorganism capable of hydrolyzing castor oil and effecting ~-oxidation of the resulting hydrolysate, or a microorganism capable of effecting ~-oxidation of hydrolysate of castor oil,or a,microorganism capable oE effecting ~-oxidation of an enzymatic hydrolysate of castor oil~ in a suitable medium in the presence of the castor oil or cas-tor oil hydrolysate substrate. The use of cas-tor oil or castor oil hydrolysate as the substrate is deter-mined by -the microorganism(s) employed in the process.
A co-oxidant may ~e added to the culture medium in order to increase the yield of the process.
The selection of the appropriate microorganism for the process is crucial depending on the embodiment of the invention employed, the yield of product required, and the resistance to the toxicity of the fatty acids found in -the castor oil hydrolysate.
The microoryanisms in the inven-tion may be bacteria, yeast or filamentous fungi. Where a microorganism is employed to hydrolyze the castor oil substrate and ~-oxidize the resulting hydrolysate, the preEerred microorganisms are~ erc~_llus oryzae, Candida rUc3Osa~
Geotrichum klebahn~l or _arrow~a llpolytica, (formerly known as Saccharomycopsis lipolytica and previously __ _ Candida _ipolytica), more preferably Yarrowia ~ olytica.
Where the microorganism is employed to only ~-oxidize castor oil hydrolysate, the preferred microorganisms are- Hansenula saturnus, Candida guilliermondii, Candida _bicans r andida krusei, Candida parakrusei, Candida pseudotropicals, Candida stellatoidea,Candida -tropicalis, Asperyi lus oryzae, Candida rugosa, Geot.richum klebahnii or Yarrowia lipoly ica, more __ _ ___ __ __ preferably Candida guilliermondii. Where the 3~ )3 n:icLoor~lLln:ism is used in colllb; nat:ion wi th a 1 :ipase and with castor oi.l, the p:re:Ferrcd Inicroor(J.lnisrns are:
rl lnsellu]a sat-lrn-ls, Ca~ da yu~]llermond:L.L, C~.~nclida alb C~llS, C_ndida ?s~.use , Ca~ da ~aL-akrusel, Candlda ~_udotro~icalis, Cand;da s-te]latoidea, Candida _ . ., ~
tr_e~cal:Ls, As~ .us oryza_, C_ndida _u~Losa, Geo ri.chum kl_bah_il or Yar_ow a ~ lk~t ca, more preferably Candida q~ ermondllO Generally, any type of llpase enzyme may be used to hydrolyze the castor oil, including microbial, pancreatic, fungi or yeast.
I~lerea lipase is used with -the microorganism in the process of the invention, the formation of -the enzymatic hydrolysate may be controlled by limiting the amount of lipase used in the process. This will avold toxicity resulting from the presence of excessive amounts of hydrolysate. The appropria-te amount of lipase require~ may be conveniently found by experimen-tation and will depend upon the lipase and microor-ganism used and the culturing conditions. The hydrolysis using li.pase .is most preferably carried out concur-ren-tly with the fermentation in the same reaction vessel. However, the hydrolysis may be carried out prior to fermentatlon if appropriate measures are taken to avoid the toxic effect of the hydrolysate.
When castor oil is used in the invention, the concern for toxicity is eliminated because triglycerides are not toxic to the organisms. Additionally, the use of castor oil and castor oil hydrolysates as the substrate 3~6 provide co-oxidants to t~e pLocess wh;ch :inc~c.lse efflcierlcy due to the presence of other Eatty acids upon hydrolysis of the castor oil.
s The form in which the microorgan:isms are used is not critlcal. They can be used as -the culture (suspen-sion), i.e., including the cells and the corresponding nutrient solution, or in the form of cells suspended in a buffer solution. The cells or an enzyme extrac-t thereof may be immobilized on a suitable solid support which may then be used to efEec-t the trans-forma-tions .
The cul-ture susperlsion is prepared by inocula-tion of a suitable medium with the m;croorganism. ~ suitable medium is one which contains carbon sources, nitrogen sources, inor~anic salts and growth factors~ Among -the suitable carbon sources are Eor example, glucose, galactose, L-sorbose, rnaltose, sucrose, celloblose, trehalose, L-arabinose, L.-rhamnose, ethanol,glycerol, L-erythri-thol, D-mannitol, lactose, melibiose, raf-finose, meleritose, starch, ~-xylose, D-sorbitol, ~-me-thyl-D-glucoside, lactic acid, ci-tric acid and succinic acidO Among the suitable nitro~en sources are, for example, nitroc3en-containing oryanic substan-ces such as peptone, meat extract, yeast extract, corn steep liquor,and casein, urea, amino acids,or nitro~en COIItailli.11(3 :inorg.~ ic colllpound.s such as nilr.ltes, nitri--les,and inorc3an:ic amnlonium salL-s. ~rnony tllc suitabLe inorganic salts are/ for ex~ ple, phosp}lates, magnes:iuin, potassium, ca]clum~ sodium. The above mentioned nutrients in -the culture ~ned:ium may be supplemented with, for example, one or rnore vitam;ns of the B Group and~or one or more trace minerals such as Fe, Mo, Cu, Mn, B as desired. I-lowever, the process can be per-formedinavitamin--free medium, for example, when a small amount of yeast extract is added to the medium there is no need for vitamins or -trace minerals.
The cultivat:ion of the microorganism can be carried out as a stationary culture or as a submersed culture (e.g., shaking culture, fermentors) preLerably under aerobic conditions. One suitably may work in the pH ranye of Erom about 3.5 to abou-t 8.0, and preferably in the range of from about 4.0 to about 7.5. The pH may be regulated by the addition of inorganic or organic bases, such as sodium hydrox:ide, potassium hydroxide, calcium hydroxide, calcium carbon ate, by ion-exchange resins, or by the addition of a l~uffer such as phosphate or phthalate. The incubation -tem-perature is suitably maintained at between about 15C
and about 33C, with a range from about 20C to about 30~C being preferred.
The process in accordance with the invention is con~
veniently carried out by adding castor oil or castor oil hydrolysate, as the substrate, to the culture medium a~ the onset of cultivation, as the sole carbon source. Alternatively, the substrate may be added in combination with another carbon source, such as c~c~ ose, eitller du~ g c~ll.t.iv.ll-ion, or when cul-tivatioll is comple-te~ 'he amount, level,or conccn(-r.lt:i.on of the subs-t:ra-te in ~he m-di.um may vary. For cxample, in the case of hydro1yzed casl:or oil,levels of f:rom about 0.3~-to abou-t 5~ may make up -the med;um i.nitially or be added during -the course of the fermenta-tion, whereas substantially any level of castor oil may be used.
The reaction time may vary depending on the composition of the culture medium and the substrate concentration.
In general, shaking flask cultures require Erom between about 2h. and about 240h. depending upon the microorganism and the composition oE the cultllre medium. However, when a fermentor is used the Eermen-tation time may be :reduced to ahout 100 h- or less.
The ferMentation may be carr:ied out using the cells of the mlcroorcJanism isolated from the culture solution, or with an enzyme extract isolated from the cells in a manner known per se. In this case, the fermenta-tion can be conveniently carried out in aqueous solution, for example in a buffer solution, in a physiological salt solution, in a fresh nutrient solution~or in water. The isolated cells or enzyme extract may be immobilized on a solid support and the desired trans-formation effected in the absence of the live micro-oxganism~ The transformation of the substrate may be effected by mutants of the microorganism. Such mutants can be obtained readily by methods well known in the art, for example, by exposing the cells to W or X-rays, or customary mutagenic substances such as for example, acridine orange.
The substrate is genercllLy added cl:irectLy to the medium A surface-actlve agent or dispersLon agent, such as Tween ~0*(polyoxyethylenesorbitarl monostearate), can also be added to an aqueous suspenslon of the substrate. Conventional 5 an-tifoam agents, such as silicone oils (e.g. ~CON*), polyalkylenegLycol derivatives, maize oil, or soya oi] can be used to control foaming.
The transformation of the substrate can be monitored using standard analytical techniques such as GLC, TLC, HPLC, IR
and NMR. If a rapid disappearance of the subs-trate is observed, more substrate can then be added in order to maximize the transformation capacity of the microorganisms. The incubation is generally -terminated when all the substrate has disappeared from the culture medium.
After the fermentation process is complete, the ~-hydroxydecanoic acid can either be lactonized in the medium to form ~-decalactone or isolated and purified by conventional -techniques including solvent extraction and distillation. When ln .situ lactonization is desired, the pH of the medium is adjusted to between about 1 and about 5, preferably between about 1 and about 3, by the addition of a suitable acid, such as hydrochloric acid, and the resulting mixture heated to between about 50 C and about 100 C, preferably between ahout 70 C and about 100 C
for about ten minutes, depending upon -the temperature, to convert the ~-hydroxydecanoic acid to y-decalactone. The ~-decalactone is then recovered and purified by standard techniques. If the r-hydroxydecanoic acid is recovered, it may be lactonized according to known procedures ~see, for example, I.L. Finar, Organic Chemis-try, 6th ed.~ Vol.l, p 469 (1973)].
* -trade mark 'L`lle foll.(>w:iT~cl ~'X~llllp~ S S(?:l.VC,' I:.o :i.~ sL::r~ rnbod:irn(~nts oE the :irlvelllion as it is now prcferred l:o practice it ~u-t ;n no way are Inea!lt to ];mit the scope thereof.
Unless othe1-wise stated, we:iyhts are in grams, tempera-tures are in deyrees cen-tic3rade and pressure in mm l~g.
EXAMPLE I
__ _ __ _ A flask containing 100 ml of 2% beef extract and 0.02%
Tween 80 was autoclaved at 120C. for 20 minutes. The medium was then inoculated with 107 cells Yarrowia lipolytica ~Saccharomyco~sls l:L~ol~_i a)/ml of medium, and lOg of castor oil added. The culture was incubated at 26C. on a rotary shaker (200 rpm) for one week The pH of the medium was occasiona]ly adjusted to 6.5-7Ø A-t the end of the Eerrnentation period -the pH of the medium was adjusted to 1.5 by the addition of mineral acid, and the mixture heated at 100C. for 10 minu-tes. AE-ter cooling, the organic products were extracted w;th hexane, the hexane evaporated, and the resiclue dis-tilled to provide 0.61g ~-deca]actone having a GLC purity of 90%.
EXAMPI,E II
The procedures and-rnaterials similar to those descrihed ln Example I were followed~except 0.05g decanoic acid was added each day. There was obtained 0.69g y-decalactone having a GLC purity of 92%.
3~
-- 1.0 --EXAMPLE :r 1 i _ . _ _ . .
The procedures arld mater:ials similaL to those described in Example I, except that Candida guillie mondil was used and 3y were Eollowed of caster oil hydroLysate was added. There was obtained the deslred product-~ -decalactone in 34~ yield.
EXAMPLE IV
By employing the procedures and materials similar to those described in Example I except that lipase is added in conjunction with castor oil, there may be obtained the desired product,'~-decalactone.
EXAMPLE V
By employing the procedures and materials similar to -those described in Examples I, I:[, and III except that other members of the genus Candida such as C. albicans, C krusei lS C. parakrusei, C. pseudotropicalis, C. stellatoldea, C. tropicalis, etc., are used, there may be obtained the desired ~-decalactone.
EXAMPLE VI
By employing the procedures and materials similar to -those described in Example I, except that as a microorganism asperg,illus oryzae is used and 3g of castor oil is added, there is obtained the desired product ~-decalactone (0.3~g/L).
j/~
1~"3~
EX~MPI,E VII
. _ . _, . . _ _ . ... . _ By elllpl.oying lhe procedures and materia].s sim;lar to those descr;bed .in Exalnp].e I, except -that as a micro-organism Geotrichum klebahllii is used alld 3g oE castor oil is added, -there is obtained the desired product y-deca]ac~one (0.2g/L).
EXA~1PLE VIII
By employing the procedures and materials si.milar to those described in Example I, except that as a mi.cro-organism Candida gui.lliernond.ii is used and to each 1,00 ml of medium 100 mg of a lipase (steapsin, Nutritional Biochem Corp.) is added, the des;.red product y-decalactone may be obtai.ned.
The invention being thus described, i.t will be obvious that the sarne may be varied in many ways. Such vari-ations are not to be regarded as a departure from the spirit and scope of the inven-ti.on and all such modlfi-cations are intended to be included within the scope of the fol].owing claims:
Claims (14)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of producing optically active .gamma.-hydroxy-decanoic acid which comprises adding a lipase or a microorganism capable of hydrolyzing castor oil to a medium containing castor oil, and a microorganism capable of .gamma.- oxidizing the resulting hydrolysate to produce .gamma.-hydroxydecanoic acid.
2. A method as in claim 1, wherein said oxidizing and said hydrolyzing microorganism are the same.
3. A method in accordance with claim 2, wherein said microorganism is Aspergillus oryzae, Candida rugosa, Geotrichum klebahnii or Yarrowia lipolytica.
4. A method in accordance with claim 1, wherein the .gamma.-hydroxydecanoic acid is lactonized in situ to form .gamma.-decalactone and the resulting .gamma.-decalactone is recovered.
5. A method in accordance with claim 1, wherein the .gamma.-hydroxydecanoic acid is recovered and lactonized to form .gamma.-decalactone.
6. A method in accordance with claim 1, wherein a co-oxidant is added to, or present during the culturing or incubating of the microorganism.
7. A method of producing optically active .gamma.-hydroxydecanoic acid which comprises culturing or incubating a microorganism capable of effectinh .beta.-oxidation of castor oil hydrolysate in the presence of castor oil hydrolysate to produce .gamma.-hydroxydecanoic acid.
8. A method in accordance with claim 7, wherein said microorganism is Hansenula saturnus, Candida guilliermondii, Candida albicans, Candida krusei, Candida parakrusei, Candida pseudotropicalis, Candida stellatoidea, Candida tropicalis, Aspergillus oryzae, Candida rugosa, Geotrichum klebahnii or Yarrowia lipolytica.
9. A method in accordance with claim 7, wherein the .gamma.-hydroxydecanoic acid is lactonized in situ to form .gamma.-decal-actone and the resulting .gamma.-decalactone is recovered.
10. A method in accordance with claim 7, wherein the .gamma.-hydroxydecanoic acid is recovered and lactonized to form .gamma.-decalactone.
11. A method in accordance with claim 7, wherein a co-oxidant is added to, or present during the culturing or incubating of the microorganism.
12. A method in accordance with claim 2, wherein said microorganism is Hansenula saturnus, Candida guilliermondii, Candida albicans, Candida krusei, Candida parakrusei, Candida pseudotropicalis, Candida stellatoidea, Candida tropicalis, Aspergillus oryzae, Candida rugosa, Geotrichum klebahnii or Yarrowia lipolytica.
13. A method in accordance with claim 1 in which the lipase enzyme is microbial, pancreatic, fungi or yeast.
14. A method of producing optically active .gamma.-hydroxydecanoic acid which comprises fermenting Yarrowia lipolytica in the presence of castor oil and a co-oxidant to produce .gamma.-hydroxy-decanoic acid and lactonizing the .gamma.-hydroxydecanoic acid in situ to form .gamma.-decalactone by adjusting the pH of the fermentation media and recovering said .gamma.-decalactone.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30609181A | 1981-09-28 | 1981-09-28 | |
| US306,091 | 1981-09-28 | ||
| US2/01323 | 1982-09-27 | ||
| PCT/US1982/001323 WO1983001072A1 (en) | 1981-09-28 | 1982-09-27 | Production of gamma-decalactone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1191103A true CA1191103A (en) | 1985-07-30 |
Family
ID=26766770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000412362A Expired CA1191103A (en) | 1981-09-28 | 1982-09-28 | Production of gamma-decalactone |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1191103A (en) |
-
1982
- 1982-09-28 CA CA000412362A patent/CA1191103A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4560656A (en) | Production of γ-decalactone | |
| Kubicek et al. | Citric acid fermentation | |
| US6001615A (en) | Enzymatic reduction of ketone groups in 6-cyano-3,5-dihydroxy-hexanoic alkyl ester | |
| CA1043283A (en) | Production of 2-keto-l-gulonic acid from glucose by mixed cultures | |
| US5108917A (en) | Process for the preparation of ibuprofen | |
| US5492818A (en) | Method of producing L-glutamic acid by fermentation | |
| EP0111683A1 (en) | Improved strain of Clostridium acetobutylicum and process for its preparation | |
| EP0417203B1 (en) | Process for the preparation of gamma and delta lactones | |
| Yoshida et al. | Microbial production of pyrogallol through decarboxylation of gallic acid | |
| Liu et al. | Cultural conditions and some properties of the lipase of Humicola lanuginosa S-38 | |
| CS217986B2 (en) | Method of making the 2-keto-l-gulonic acid | |
| Guevarra et al. | Production of 2-hydroxyparaconic and itatartaric acids by Ustilago cynodontis and simple recovery process of the acids | |
| CA1191103A (en) | Production of gamma-decalactone | |
| US5409820A (en) | Process for the production of lovastatin using Coniothyrium fuckelii | |
| EP0054311B1 (en) | Process for producing l-glutamic acid | |
| US5075233A (en) | Process for the preparation of 2-aryloxypropionic acids | |
| CA1302931C (en) | Preparation of pyruvic acid | |
| DE69839248T2 (en) | PROCESS FOR THE PREPARATION OF INHIBITORS OF HMG-CoA REDUCTASE. | |
| CA1140878A (en) | Preparation of 2,5-diketogluconic acid | |
| JP2719693B2 (en) | Fermentation method to produce squalene and ethanol simultaneously | |
| CA2289553C (en) | Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid | |
| CA1119981A (en) | Process for preparing 2,5-diketogluconic acid | |
| JPH0690772A (en) | Preparation of optically active gamma- hydroxydecanoic acid | |
| SI9800144A (en) | New biotechnological process for producing of 3-hidroxy-ml-236b derivatives known as m-4 and m-4' | |
| KR100249870B1 (en) | Method for preparing 3-hydroxyphenylacetic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |